<?xml-model href='http://www.tei-c.org/release/xml/tei/custom/schema/relaxng/tei_all.rng' schematypens='http://relaxng.org/ns/structure/1.0'?><TEI xmlns="http://www.tei-c.org/ns/1.0">
	<teiHeader>
		<fileDesc>
			<titleStmt><title level='a'>Total Synthesis of (±)-Phaeocaulisin A Enabled Chemistry Innovation and Biological Discovery</title></titleStmt>
			<publicationStmt>
				<publisher>Thieme</publisher>
				<date>01/01/2026</date>
			</publicationStmt>
			<sourceDesc>
				<bibl> 
					<idno type="par_id">10680318</idno>
					<idno type="doi">10.1055/a-2706-0821</idno>
					<title level='j'>Synlett</title>
<idno>0936-5214</idno>
<biblScope unit="volume">37</biblScope>
<biblScope unit="issue">02</biblScope>					

					<author>Chang Liu</author><author>Mingyu Zhang</author><author>Mingji Dai</author>
				</bibl>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract><ab><![CDATA[<title>Abstract</title> <p>Guaianolide sesquiterpene natural products are of great biological and synthetic importance. Among them, phaeocaulisin A with a unique tetracyclic skeleton was isolated in 2013 and found to exhibit anticancer cell proliferation activity and anti-inflammatory activity. The first total synthesis of ( − )-phaeocaulisin A was achieved by Procter and coworkers in 2022. Two years later, we reported a total synthesis of ( ± )-phaeocaulisin A. The key steps of our total synthesis include a novel palladium-catalyzed cyclopropanol ring-opening carbonylative esterification to access a key γ-ketoester, a regio- and stereo-selective aldol cyclization to build the 7-membered carbocycle, and a cascade ketalization/lactonization to construct the tetracyclic skeleton. This Synpact article reflects our journey toward ( ± )-phaeocaulisin A, which also led to the discovery of an analogue with potent anticancer activity against triple negative or HER2+ breast cancer.</p>]]></ab></abstract>
		</profileDesc>
	</teiHeader>
	<text><body><div/></body></text>
</TEI>
